July 202552

Hair transplant tourism was reported to pair low prices with permissive regulation, unsupervised technicians and unreported complications. PRP combined with 5% minoxidil was found to improve hair parameters more than either alone. Microtrauma therapies including microneedling and lasers were reported to promote regrowth through wound-healing responses. Topical minoxidil was reported to add about 21 hairs/cm², with oral and topical working similarly. A comprehensive prevention protocol after transplantation was reported to cut postoperative edema from 8.94% to 2.66% with no severe cases. Telogen effluvium in balding men was reported to precede follicle miniaturization. Microneedling radiofrequency with topical exosomes was reported to increase hair density and diameter. A 1565-nm fractional laser was reported to visibly improve scalp hair appearance. Fecal microbiota transplantation in mice was reported to promote hair growth.

  1. Association Between Androgenetic Alopecia and Glucagon‐Like Peptide‐1 Receptor Treatment in Type 2 Diabetes Mellitus Patients: A Retrospective Cohort Study a retrospective cohort study examines whether GLP-1 receptor agonist treatment is associated with androgenetic alopecia in type 2 diabetes patients. Androgenetic Alopecia International Journal of Dermatology
  2. The Allures and the Alarms of the Hair Transplant Tourism Industry A review warns hair transplant tourism offers low prices but permissive regulation, unsupervised technicians, bait-and-switch marketing and unreported complications leave patients vulnerable; international standards are urged. Hair Transplant Aesthetic Plastic Surgery · 5 citations
  3. Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatments A retrospective comparison found PRP combined with 5% minoxidil improved hair parameters more than either treatment alone in androgenetic alopecia, especially reducing vellus hair. Androgenetic AlopeciaPlatelet-Rich Plasma Journal of Dermatological Treatment
  4. The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia. A review finds microneedling, lasers, low-level laser therapy and PRP promote regrowth through wound-healing immune responses, with demonstrated efficacy in androgenetic alopecia and alopecia areata. Scarring Alopecia
  5. Comprehensive Prevention for Edema after Hair Transplantation: A Multicenter Study of 1167 Patients In 1167 hair-transplant patients, a comprehensive prevention protocol cut postoperative edema from 8.94% to 2.66% with no severe cases, versus triamcinolone tumescent solution. Plastic & Reconstructive Surgery · 3 citations
  6. Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy. A review: topical minoxidil adds about 21 hairs/cm² versus 5–9 with placebo over 16–48 weeks; oral and topical minoxidil work similarly with different side effects. Androgenetic AlopeciaMinoxidil
  7. You cannot go bald without first, losing your hair: Telogen effluvium is a precursor to, prerequisite for and potentially an incitant to common baldness in men In balding men, shortening of the anagen growth phase (telogen effluvium) precedes follicle miniaturization, suggesting shedding is an early step toward pattern baldness. Telogen Effluvium Clinical and Experimental Dermatology
  8. Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial In a 40-patient randomized trial, triamcinolone injections improved patchy alopecia areata (SALT scores down 54%) while intralesional methotrexate patients worsened. Alopecia Areata Journal of Cosmetic Dermatology
  9. Fecal microbiota transplantation promotes hair growth through gut microbiome and metabolic regulation Genetic analysis linked low gut Lactobacillus to androgenetic alopecia, and in mice fecal transplant and L. rhamnosus GG promoted hair growth. Life Sciences · 1 citation
  10. Fucoidan treatment reverses hair loss and inhibits inflammatory responses in a mouse model of androgenetic alopecia In a mouse model of androgenetic alopecia, 2% fucoidan reversed hair loss and increased density via Wnt/β-catenin signaling, VEGF release, and reduced inflammation. Androgenetic Alopecia International Journal of Biological Macromolecules
  11. Microneedling radiofrequency followed by topical exosome application therapy for pattern hair loss: a scoping review and prospective study. In 20 patients, microneedling radiofrequency followed by topical exosomes significantly increased hair density and diameter over nine months, with no adverse events; RCTs are still needed. Androgenetic AlopeciaMicroneedling
  12. Bifunctional sodium hyaluronate microneedle patches integrating 5α-reductase and ROS regulation for boosted hair regeneration In cells and mice, a hyaluronate microneedle patch combining dutasteride micelles and antioxidant nanoparticles lowered DHT and ROS and accelerated hair growth. International Journal of Biological Macromolecules
  13. Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis In 106 patients with alopecia totalis or universalis, topical immunotherapy gave excellent or good responses in 43%; atopic dermatitis predicted poorer outcomes. Alopecia TotalisAlopecia Universalis Frontiers in Medicine
  14. Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial In a 107-child trial, topical botanical Cinainu beat placebo for moderate-to-severe alopecia areata at 24 weeks, with benefits sustained to 48 weeks and good tolerability. Alopecia Areata British Journal of Dermatology · 3 citations
  15. Sinapic acid and glabridin synergistically mitigate androgenetic alopecia by modulating ferroptosis through stabilization of β-catenin against ubiquitin-dependent degradation. In AGA mice, sinapic acid plus glabridin synergistically promoted hair growth by blocking ferroptosis and stabilizing β-catenin in dermal papilla cells. Androgenetic Alopecia
  16. Optimizing Efficacy: Hyaluronic Acid Liposomes Encapsulating Minoxidil for Enhanced Transdermal Delivery and Treatment of Androgenetic Alopecia In mice, a hyaluronic-acid liposome minoxidil formulation improved skin penetration and retention, reduced inflammation, and accelerated hair growth versus standard delivery. Androgenetic AlopeciaHyaluronic AcidMinoxidil Colloids and Surfaces B Biointerfaces
  17. Improvement in Scalp Hair Appearance Following Treatment With a Non‐Ablative Fractional Laser: A Retrospective Observational Study In a 132-patient retrospective study, blinded reviewers correctly identified post-treatment photos 96.9% of the time after 1565-nm fractional laser for AGA. Lasers in Surgery and Medicine
  18. Cancer-Related Alopecia Risk and Treatment Opinion review: scalp cooling first-line to prevent chemotherapy hair loss, topical minoxidil for regrowth; oral minoxidil urged cautiously until oncology safety data are available. Tretinoin Current Treatment Options in Oncology · 10 citations
  19. Hair Transplant: Patient Candidacy, Medical Optimization, and Surgical Considerations A review covers how to select hair transplant candidates, optimize medical therapy beforehand, and manage surgery and postoperative complications. Hair Transplant International Journal of Dermatology
  20. The GPR30 agonist G-1 promotes hair growth via Wnt/Hedgehog signaling in mice In mice and human dermal papilla cells, GPR30 agonist G-1 activated Wnt/Hedgehog signaling and promoted hair growth, suggesting a novel estrogen-pathway target. Frontiers in Pharmacology
  21. Frontiers in the physiology of male pattern androgenetic alopecia: Beyond the androgen horizon A review examines what drives male pattern hair loss beyond androgen signaling and maps open questions and potential future drug targets. Androgenetic Alopecia Physiological Reviews
  22. Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study Real-world ritlecitinib for severe alopecia areata produced higher SALT20 response rates than the pivotal ALLEGRO trial, a three-center Italian review found. Alopecia AreataRitlecitinib Clinical and Experimental Dermatology · 3 citations
  23. Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study In a pilot RCT, PRP raised hair density in breast cancer survivors with endocrine- or chemo-induced alopecia, but no more than untreated scalp; no tumor seeding was observed. Anagen EffluviumPlatelet-Rich Plasma Dermatologic Surgery
  24. Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review A review assessing which alopecia areata, androgenetic alopecia, and scarring alopecia medications are safe for breast cancer patients and high-risk women. American Journal of Clinical Dermatology
  25. Serotonin activates dermal papilla cells and promotes hair growth In hair follicle organoids and organ cultures, serotonin and the agonist sumatriptan promoted hair shaft elongation. Scientific Reports
  26. Alopecia Treatments in Breastfeeding: Safety and Clinical Considerations A review mapping which alopecia areata, androgenetic alopecia, and scarring alopecia treatments transfer into breast milk and their potential infant effects. International Journal of Dermatology
  27. Single‐Cell RNA Sequencing Highlights a Contribution of Human Amniotic Mesenchymal Stem Cells‐Derived Exosomes to Androgenetic Alopecia In AGA mice, human amniotic stem-cell exosomes accelerated hair growth by protecting dermal papilla cells from DHT damage via Wnt/β-catenin signaling. Androgenetic AlopeciaExosomes The FASEB Journal
  28. Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study In 44 patients, fewer prior systemic treatments (low therapeutic burden) predicted significantly better response to baricitinib for alopecia areata over 12 months. Alopecia AreataBaricitinib Dermatology and Therapy
  29. Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity In human hair follicle cultures, adding antioxidants like N-acetylcysteine to scalp cooling prevented chemotherapy-induced follicle damage even at suboptimal cooling temperatures. Frontiers in Pharmacology · 4 citations
  30. Modified Huanjingjian Prevents Chemotherapy-Induced Alopecia by Inhibiting Genomic DNA Methylation of the Wnt Signaling Pathway in Mice In mice, a modified Chinese herbal formula prevented cyclophosphamide-induced hair loss by reactivating Wnt signaling through DNA demethylation in follicle stem cells. Anagen Effluvium Drug Design Development and Therapy · 3 citations
  31. Activity‐based therapeutic algorithm for folliculitis decalvans: A practical tool for effective management proposes an activity-based therapeutic algorithm as a practical tool for managing folliculitis decalvans. Folliculitis Decalvans Journal of the European Academy of Dermatology and Venereology
  32. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024 A 69-expert Delphi consensus on frontal fibrosing alopecia agreed on only 56% of questions, with strongest agreement on disease monitoring and weakest on physical therapies. Frontal Fibrosing Alopecia Journal of the European Academy of Dermatology and Venereology · 2 citations
  33. [Artículo traducido] Comparación entre la aplicación subcutánea vs. subcutánea e intramuscular combinada de toxina botulínica para el tratamiento de la alopecia androgenética: un ensayo clínico aleatorizado A randomized trial found a single botulinum toxin session, subcutaneous or combined, did not improve hair density or quality in men with AGA at six months. Actas Dermo-Sifiliográficas
  34. Alopecia Areata Associated with Dupilumab: National Database Study In a matched database study, dupilumab users with atopic dermatitis had modestly higher alopecia areata risk (OR 1.44); authors urge scalp monitoring but call for confirmatory research. Alopecia Areata Diagnostics · 1 citation
  35. Comparative analysis of 3D and 2D cell-culturing methods in hair follicle spheroid morphogenesis and drug responsiveness In lab cultures, 3D hair-follicle spheroids responded as expected to minoxidil, but 2D cultures responded better to DHT. Biomaterials Advances · 1 citation
  36. Regenerative<sup>®</sup> Hair Transplant: Innovation in Hair Transplantation Regenerative<sup>®</sup> Hair Transplant. A technique combining hair transplant with autologous mesenchymal stem-cell injection; authors claim better density but report only cell characterization, no patient outcomes. Hair Transplant
  37. Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia Single-cell and spatial sequencing of lichen planopilaris scalp identifies interferon-γ and macrophage-derived oncostatin M as drivers of follicular scarring and potential drug targets. Scarring Alopecia Cell & Bioscience
  38. A Brief Review of Scalp Biopsy and its Interpretation A review giving practical recommendations on scalp biopsy site choice, technique, and interpretation for diagnosing alopecias. Indian Dermatology Online Journal · 1 citation
  39. Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study In 85 patients, yellow dots, black dots, broken hairs and coudability hairs signalled poor-prognosis alopecia areata, while vellus hairs indicated a favorable outcome. Alopecia Areata Indian Dermatology Online Journal · 1 citation
  40. “Factors Influencing Patient Satisfaction in Frontal Hairline Correction with Hair Transplantation: A Multicenter Retrospective Study” In 736 hairline-transplant patients, satisfaction varied by sex and was predicted by age, hair direction, selfie interest, and cost-to-income ratio. Plastic & Reconstructive Surgery
  41. Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy A post-hoc trial analysis found ritlecitinib normalized immune gene expression in alopecia areata scalp, and these molecular shifts correlated with subsequent hair regrowth. Alopecia AreataRitlecitinib Allergy
  42. Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color examines misdiagnoses of hair and scalp disorders in adult patients with skin of color. International Journal of Dermatology · 1 citation
  43. Regenerative Hair Pigmentation via Skin Organoids: Adaptive Patterning Mediated by Collagen VI and Semaphorin 3C In skin organoids, collagen VI and semaphorin 3C signaling guide melanocytes into their follicle niche to restore hair pigmentation. Advanced Science
  44. FR- Mesoterapia con bicalutamida: una nueva alternativa para la alopecia androgenética Bicalutamide mesotherapy is presented as a new alternative for androgenetic alopecia. Actas Dermo-Sifiliográficas
  45. Immune‐Mediated Disorders in Patients With Alopecia Areata: Systematic Review and Meta‐Analysis A meta-analysis links alopecia areata to higher odds of vitiligo, lupus, autoimmune thyroiditis, atopic dermatitis and IBD, supporting routine comorbidity screening. Alopecia Areata International Journal of Dermatology · 7 citations
  46. Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata Single-cell mapping of blood immune cells in alopecia areata reveals severity-linked inflammatory and epigenetic changes, identifying candidate pathways for future therapies. Alopecia Areata Frontiers in Immunology · 4 citations
  47. CD133 defines hair-inductive cells in the dermal papilla In mouse skin-graft assays, CD133-positive dermal papilla cell spheroids grew more hairs than CD133-negative ones. Scientific Reports · 1 citation
  48. Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation A review concluding that current hair-loss treatments and transplants are limited and that iPSC-derived follicles could one day expand graft supply. Stem Cell Research & Therapy · 1 citation
  49. Vinegar-Processed Black Soybean Promotes Hair Growth and Prevents Alopecia via Wnt/β-Catenin Pathway. In mice, vinegar-processed black soybean dose-dependently promoted hair growth and reduced cyclophosphamide-induced alopecia via Wnt/β-catenin signaling.
  50. The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study Biotin Cureus
  51. Adenosine as an Active Ingredient in Topical Preparations Against Hair Loss: A Systematic Review and Meta-Analysis of Published Clinical Trials Adenosine Biomolecules · 4 citations
  52. Germination Enhances Phytochemical Profiles of Perilla Seeds and Promotes Hair Growth via 5α-Reductase Inhibition and Growth Factor Pathways Selenium Biology · 3 citations